PhaseBio Expands Executive Management Team

PhaseBio Expands Executive Management Team
Company Appoints Kristopher L. Hanson as Vice President, Head of Legal and Glen Burkhardt as Vice President of Human Resources

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced the expansion of its executive management team with the appointment of Kristopher L. Hanson as Vice President, Head of Legal and Glen Burkhardt as Vice President of Human Resources.

“PhaseBio has achieved critical milestones this year and is making solid progress in the advancement of PB2452, a novel agent for the reversal of the antiplatelet activity of ticagrelor,” said Jonathan P. Mow, Chief Executive Officer of PhaseBio. “These additions to our management team allow us to more efficiently prepare for the submission of a Biologics License Application for PB2452 and for potential accelerated approval and commercial launch. We are delighted to welcome Kris and Glen, two seasoned leaders with extensive biopharmaceutical industry experience, to the team.”

READ:  Galera Therapeutics to Participate in Fireside Chat at 2020 BTIG Virtual Biotechnology Conference

Mr. Hanson will oversee and manage the company’s legal affairs, including support of clinical development efforts, strategic and licensing transactions, corporate governance, compliance and other key areas. Prior to joining PhaseBio, Mr. Hanson served as Vice President, Legal & Compliance and Head of Human Resources for Nalpropion Pharmaceuticals where, as a member of the company’s executive management team, he had responsibility for the company’s legal, compliance and human resources functions. Prior to Nalpropion, he served as Vice President and Assistant General Counsel for Orexigen Therapeutics and before that worked in senior legal roles at Lytx, Cricket Communications and SAIC. He received his JD from UCLA School of Law and his BA from Georgetown University.

With more than 25 years of human resources experience in the life sciences industry, Mr. Burkhardt will oversee the human resources department of PhaseBio. Prior to joining PhaseBio, he was a founding principal for Landscope Life Science Consulting, LLC. He has also served as Vice President of Human Resources for Hologic, Inc., prior to which he was Senior Director of Human Resources at Onyx Pharmaceuticals from 2011 until its sale to Amgen in 2014. Earlier in his career, Mr. Burkhardt held several human resources roles at Eli Lilly and Company, including leadership of its global talent management function. He received BS and BArch degrees from Ball State University and an MBA from the Indiana University Kelley School of Business.

READ:  Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data

Source: PhaseBio Pharmaceuticals, Inc., One Great Valley Parkway, Suite 30, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee